BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu QJ, Lv JX, Liu J, Zhang XB, Wang LB. Nucleobindin-2 Promotes the Growth and Invasion of Glioblastoma. Cancer Biother Radiopharm 2019;34:581-8. [PMID: 31697592 DOI: 10.1089/cbr.2019.2829] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ren L, Bao D, Wang L, Xu Q, Xu Y, Shi Z. Nucleobindin-2/nesfatin-1 enhances the cell proliferation, migration, invasion and epithelial-mesenchymal transition in gastric carcinoma. J Cell Mol Med 2022. [PMID: 36065769 DOI: 10.1111/jcmm.17522] [Reference Citation Analysis]
2 Kmiecik A, Ratajczak-wielgomas K, Grzegrzółka J, Romanowicz H, Smolarz B, Dziegiel P. Expression of NUCB2/NESF-1 in Breast Cancer Cells. IJMS 2022;23:9177. [DOI: 10.3390/ijms23169177] [Reference Citation Analysis]
3 Zhou Q, Liu Y, Feng R, Zhang W. NUCB2: roles in physiology and pathology. J Physiol Biochem 2022. [PMID: 35678998 DOI: 10.1007/s13105-022-00895-4] [Reference Citation Analysis]
4 Qi Q, Sun Y, Yang Y, Liu Y. Circ_0000274 contributes to renal cell carcinoma progression by regulating miR-338-3p/NUCB2 axis and JAK1/STAT3 pathway. Transplant Immunology 2022. [DOI: 10.1016/j.trim.2022.101626] [Reference Citation Analysis]
5 Kmiecik AM, Dzięgiel P, Podhorska-Okołów M. Nucleobindin-2/Nesfatin-1-A New Cancer Related Molecule? Int J Mol Sci 2021;22:8313. [PMID: 34361082 DOI: 10.3390/ijms22158313] [Reference Citation Analysis]
6 Skorupska A, Lenda R, Ożyhar A, Bystranowska D. The Multifaceted Nature of Nucleobindin-2 in Carcinogenesis. Int J Mol Sci 2021;22:5687. [PMID: 34073612 DOI: 10.3390/ijms22115687] [Reference Citation Analysis]